Concentrated insulin safety
Humulin R U-500: the pen displays units, not a conversion problem
A correct concentration calculation can become a dangerous counseling instruction. Humulin R U-500 has specific pen and syringe rules. Learn what the device already measures before multiplying or dividing the prescribed units.
Sources checked October 11, 2026. Independent educational content, not NABP exam questions or individual treatment advice.
Separate concentration from displayed dose
U-500 contains 500 units/mL, five times the concentration of U-100. That comparison explains why device errors matter; it does not mean the pen dial must be multiplied by five. The U-500 KwikPen is designed to display and deliver U-500 insulin units.
The label instructs patients to dial and dose the prescribed number of units without conversion. A prescription for 80 units is not an instruction to dial 16 because the concentration is fivefold higher. Confirm the product and device before supplying any numerical instruction.
Do not use a syringe to empty the pen
Withdrawing U-500 from a KwikPen into a syringe defeats the intended delivery system. The label warns that syringe markings can measure the dose incorrectly and cause a severe overdose. A patient who lacks pen needles needs help with the supply problem, not instructions to improvise.
This is separate from vial use. Patients using a U-500 vial should receive a U-500 insulin syringe and be told that no dose conversion is required. A U-100 or tuberculin syringe is not the labeled substitute.
Keep the regimen and route product-specific
Humulin R U-500 is indicated for patients requiring more than 200 units of insulin per day. The label describes subcutaneous administration two or three times daily approximately 30 minutes before meals. It should not be given intravenously, mixed with other insulins or used in an insulin pump.
A learner who recognizes regular human insulin may recall an intravenous protocol for a different presentation. Do not transfer that protocol to U-500. The concentration, formulation, device and route must all match the actual product instructions.
Use teach-back rather than a reassuring label check alone
Ask the patient to identify the insulin, device, prescribed units and timing, then show how the dose is selected. Never share a pen between patients, even with a new needle. Changing insulin regimens requires close medical supervision and more frequent glucose monitoring.
A correct written prescription is only one barrier against harm. The worked case below tests whether a familiar calculation is being used in the wrong context. It is an original study exercise, not a recommendation to change a real insulin regimen.
A worked case
A patient prescribed Humulin R U-500 KwikPen 80 units before a meal says they dial 16 because the medicine is five times stronger. They also plan to withdraw it with a U-100 syringe when pen needles run out. Identify both errors.
- The KwikPen displays the actual insulin units; no fivefold dose conversion is required.
- Withdrawing from the pen into a syringe is specifically prohibited.
- Resolve the needle supply and dosing misunderstanding before further use through the clinical team.
Answer: The patient should not use either improvised instruction. The device-specific plan must match the prescribed 80 units and labeled administration rules.
Try it before reading the answer
Write the key fact, decision and safety check first. These are original practice exercises, not recalled exam items.
1. Does the U-500 pen need a fivefold conversion?
No. Dial the prescribed units.
2. Which syringe is used with a U-500 vial?
A U-500 insulin syringe.
3. Can U-500 be administered intravenously because it is regular insulin?
No. The U-500 label prohibits intravenous administration.
Continue learning
Put the topic into a study planSources and scope
Source dates and limits matter. Follow the current official source for clinical or regulatory decisions. Examples are simplified teaching cases, not prescribing, diagnostic or compounding instructions. Check the full current guidance and individual clinical context.